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REGULATION OF LEUKOTRIENE C4 BIOSYNTHESIS IN CALCIUM
IONOPHORE A23187-CHALLENGED AUGUST RAT
PERITONEAL LEUKOCYTES
James M. Huebner, M.S.
Western Michigan University, 1995
Leukotriene (LT) C4 is a potent myotropic product of arachidonic acid
5-lipoxygenation that is thought to play a role in the pathophysiology of immediate
hypersensitivity reactions and inflammation.

We designed the present study to

evaluate the capacity of August (AUG) rat mixed peritoneal leukocytes to generate
+

LTC4 when challenged with different concentrations of the Ca2 ionophore A23187
and to test the hypothesis that LTC4 biosynthesis is regulated via a protein kinase C
(PKC)-dependent mechanism. The AUG rat, which has a spontaneously high number
of peritoneal eosinophils that can be harvested by a simple lavage procedure, is a
potentially important animal model of eosinophilia that has not been well
characterized. Our findings indicate that A23187-stimulated LTC4 biosynthesis is 5+

lipoxygenase activating protein (FLAP) inhibitor-sensitive and is both Ca2 +/Mg2 - and
concentration-dependent.
antagonistically
mechanisms.

via

Furthermore, LTC4 production appears to be regulated

serine/threonine-

and

tyrosine-specific

phosphorylation
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INTRODUCTION
The functional repertoire of both infiltrating and in situ inflammatory cells
includes the biosynthesis and release of leukotrienes (LTs) derived from the 5lipoxygenation of arachidonic acid (AA; 20:4). The pharmacological activities of
these compounds, their relative potencies, and their prominence in biological fluids
and inflammatory exudates suggest a role in the pathophysiology of human bronchial
asthma and other immediate hypersensitivity reactions (Lam & Austen, 1992).
Functionally, the LTs can be divided into two classes: (1) the dihydroxy acid LTB4,
which is a powerful chemotactic, aggregative, and chemokinetic agent (Ford
Hutchinson, Bray, Doig, Shipley, & Smith, 1980); and (2) the cysteinyl-containing
LTs C4, D4, and E4; collectively termed the "slow-reacting substance of anaphylaxis"
or SRS-A (Samuelsson, 1983). Whereas LTB4 has relatively few myotropic activities
(Piper, 1984), the C6 amino acid-substituted cysteinyl L Ts are potent contractors of
both vascular and non-vascular smooth muscle. Specifically, these compounds can
evoke bronchospasm and mucus secretion in human airway, increase both arteriolar
constriction and microvascular permeability, contract gastrointestinal smooth muscle,
reduce myocardial contractility and coronary blood flow, and can induce prolonged
hypotension and shock when injected systematically (see reviews; Hammarstrom,
1983; Samuelsson, 1983; Lewis & Austen, 1984; Piper, 1984; Samuelsson, Dahlen,
Lindgren, Rouzer, & Serhan, 1987; Lam & Austen, 1992).
1

2
Cellular Formation of the Cysteinyl Leukotrienes
LT biosynthesis first requires the phospholipase-catalyzed liberation of AA
from esterified stores in membrane glycerophospholipids (Irvine, 1982). Free AA is
enzymatically transformed to 5-hydroperoxyeicosatetraenoic acid (5-HPETE) via the
stereospecific insertion of molecular oxygen at C5 (Panossian, Hamberg, &
Samuelsson, 1982), and subsequently dehydrated to the epoxide 5,6-oxido-7,9,11,14eicosatetraenoic acid (LTA4 ) (Maas, Ingram, Taber, Oates, & Brash, 1982) (Figure 1).
Both reactions proceed in intact cells through the catalytic action of 5-lipoxygenase
(5-LO; EC 1.13.11.34) (Rouzer, Matsumoto, & Samuelsson, 1986), a single, iron
containing protein (Radmark et al., 1995), which translocates from the cytosol to the
nuclear membrane upon activation (Woods et al., 1993).

In human leukocytes,

optimal enzymatic activity requires a complex series of stimulatory factors including
Ca2

+

,

ATP, phospholipid and lipid hydroperoxide (reviewed in DeWolf, 1991;

Rouzer, 1991; Wong & Crooke, 1991); unfortunately, the specific properties
contributed by these agents remain largely undetermined. Another cofactor has been
identified from neutrophil cell extracts by photoaffinity labelling and affinity
chromatography

with

MK-886

{3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-

isopropylindol-2-yl]-2,2-dimethylpropanoic acid} (Miller et al., 1990; see also Gillard
et al., 1989), a selective inhibitor of its activity. Current evidence suggests that this
novel 18 kDa polypeptide, termed 5-LO-activating protein (FLAP) (Dixon et al.,
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Figure 1. 5-Lipoxygenase Pathway of Leukotriene Biosynthesis.
PLA2 , phospholipase A2 ; AA, arachidonic acid; COX, cyclooxygenase; 5-LO, 5lipoxygenase; GSH, glutathione; GGTP; y-glutamyl transpeptidase.
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1990; Miller et al., 1990), facilitates the presentation of free AA to 5-LO (Ford
Hutchinson, 1994; Miller et al., 1990), thereby increasing the efficiency of epoxide
formation while having no direct effect on subcellular 5-LO activity or AA release.
The labile epoxide LTA4 can be hydrolyzed both enzymatically to 5-S-12R
dihydroxy-6,14,8,10-eicosatetraenoic acid (LTB4) (Borgeat & Samuelsson, 1979) and
non-enzymatically to biologically inactive 6-trans-LTB4 diastereoisomers and small
quantities

of 5,6-dihydroxy-eicosatetraenoic acids

(5,6-DHETEs)

(Radmark,

Malmsten, Samuelsson, Goto, Marfat, & Corey, 1980). Alternatively, LTA4 can be
conjugated to 5S-12R-dihydroxy-6R-S-glutathionyl-7,9,11,14-eicosatetraenoic acid
(LTC4 ) via the enzymatic adduction of a reduced glutathione (GSH) to the epoxide
C6 (Radmark, Malmsten, & Samuelsson, 1980).

This reaction is catalyzed by a

distinctive membrane-localized GSH-S-transferase (LTC4 synthase; EC 2.5.1.37),
specifically dedicated to the conversion of LT� in vivo (Nicholson, Ali, Klemba,
Munday, Zamboni, & Ford-Hutchinson, I 992). Human LTC4 synthase, a homodimer
composed of two identical 18 kDa subunits, has recently been purified to
homogeneity from the monocytic leukemia cell line THP-1 (Nicholson et al., I 993)
and its cDNA cloned from THP-1 and human myelocytic KG-1 cell cDNA expression
libraries (Lam, Penrose, & Austen, 1995; Welsch, Creely, Mathis, Hauser, & Isakson,
1995). Interestingly, analysis of the predicted amino acid sequence indicate two
putative Ser-Ala-Arg consensus sequences for protein kinase C phosphorylation (Lam
et al., 1995; Welsch et al., 1995; Nicholson et al., 1993), suggesting that the enzyme.
may be phosphoregulated in vivo (see below).

This hypothesis may be of
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considerable significance, given that the conjugation of LTA4 is the first committed
step in the biosynthesis of all cysteinyl LTs, and thus in determining the extracellular
profile of these mediators in the acute and chronic inflammatory responses with
which they are associated.
However, not all cells that have the capability to synthesize LTC4 necessarily
modify the tripeptide side chain to form the lytic derivatives of this parent compound
(Piper, 1984).

+

For example, h!1ffian eosinophils stimulated with Ca2 ionophore

A23 l 87 generate LTC4 as their sole cysteinyl LT (Weller, Lee, Foster, Corey, Lewis,
& Austen, 1983).

A23187-stimulated murine mastocytoma cells (Murphy,

Hammarstrom, & Samuelsson, 1979), differentiated murine bone-marrow cells
(Razin, Mencia-Huerta, Lewis, Corey & Austen, 1983), N-formyl-Met-Leu-Phe
(FMLP)-stimulated guinea pig lung parenchemal strips (Shore, Stimler-Gerard,
Smith, & Drazen, 1987) and zymosan-stimulated murine peritoneal and pulmonary
macrophages (Rouzer, Scott, Hamill, & Cohn, 1982; Rouzer, Scott, Cohn, Blackburn,
& Manning, 1980) also do not appear to significantly convert LTC4 in vitro. In other
cells and tissues, particularly those with secretory and absorptive functions (Meister
& Anderson, 1983), LTC4 undergoes further processing by y-glutamyl transpeptidase
(GGTP; EC 2.3.2.2), yielding its cysteinylglycinyl derivative, 5S-hydroxy-6R-S
cysteinylglycyl-7,9,11,14-eicosatetraenoic acid (LTD4 ) (Oming, Hammarstrom, &
Samuelsson, 1980).

GGTP is a widely-distributed membrane-bound ectoenzyme

which catalyzes the transfer of a y-glutamyl moiety to amino acids, dipeptides, GSH

6
(i.e., autotranspeptidation) or water (Meister & Anderson, 1983; Allison, 1985; Tate
& Meister, 1985; Hammarstrom, Orning, & Bernstrom, 1986). In the bioconversion
of LTC4 to LTD4, amino acids are the preferred y-glutamyl acceptors (Hammarstrom
et al., 1986). The reaction is also readily reversible; using GSH as a substrate, GGTP
can catalyze the addition of a y-glutamyl residue to the amino group of LTD4 , thus
driving the formation of LTC4 (Hammarstrom, 1981; 1983).
Hydrolysis of the remaining peptide bond in LTD4 results in elimination of the
C-terminal glycine residue and yields the cysteinyl derivative, 5S-hydroxy-6R-S
cysteinyl-7,9,11,14-eicosatetraenoic acid (LTE4) (Bernstrom & Hammarstrom, 1981).
This reaction is catalyzed by a ubiquitous membrane-associated dipeptidase (E.C.
3.4.13.-) (Bernstrom & Hammarstrom, 1981; Sok, Pai, Atrache, Kang, & Sih, 1981;
Anderson, Allison, & Meister, 1982), an activity which cleaves several
cysteinylglycine and S-substituted cysteinylglycine substrates into their component
amino acids (Anderson et al., 1982; Tate, 1985). A further y-glutamyl derivative, 5S
hydroxy-6R-S-y-glutamylcysteine-7,9, l 1,15-eicosatetraenoic acid (LTF4), has also
been generated by incubating LTE4 with GGTP and GSH (Anderson et al., 1982;
Bernstrom & Hammarstrom, 1982) and, more recently, by incubating LTC4 with
bovine pancreas carboxypeptidase A (Reddenna, Whelan, & Reddy, 1988). However,
LTE4 is probably a more significant metabolite in vivo; LTE4 , N-acetyl LTE4 and N
acetyl-11-trans-LTE4 have long been recognized as biliary/fecal or urine products of
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endogenous cysteinyl LT metabolism in rats and primates respectively (reviewed in
Hammarstrom, Orning, & Keppler, 1988; Hammarstrom et al., 1986).

ls There a Role for Protein Kinase C Activation in the Regulation of
Cysteinyl Leukotriene Biosynthesis?
In the now classical pathway for transducing extracellular signals into cells,
agonist-induced hydrolysis of membrane inositol phospholipids results in the
transient formation of 1,2-diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3 )
(Nishizuka, 1986). Under normal conditions, DAG can induce the activation of
+

Ca2 /phospholipid-dependent protein kinase C (PKC; E.C. 2. 7.1.-) (Figure 2), which
in tum leads to the phosphorylation of specific target substrates (i.e., serine and
threonine residues), including cytoskeletal and contractile proteins, ion channels and
transporters, cell surface receptors, and a variety of soluble proteins (Nishizuka,
1986). Tumor-promoting phorbol esters, such as phorbol 12-myristate 13-acetate
(PMA), can also substitute for DAG, activating PKC directly without initiating the
hydrolysis of phosphatidylinositol (Castagna, Takai, Kaibuchi, Sano, Kikkawa, &
Nishizuka, 1982).
Under the appropriate conditions, it now appears that PKC activation
+

frequently synergizes with Ca2 mobilization to enhance certain cellular events
(Nishizuka, 1984; 1986; 1992), a phenomenon that can be demonstrated in vitro by
the selective application of a permeable DAG or phorbol diester and a ligand capable
+

of circumventing Ca2 gating mechanisms (Reed & Lardy, 1972), such as the Ca2

+
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Figure 2. The Classical Pathway of PKC Activation.
PLC, phospholipase C; Ptdlns-4,5P2 , phosphatidylinositol 4,5 bisphosphate; DAG,
diacylglycerol; PKC, protein kinase C; PMA, phorbol 12-myristate 13-acetate.
Adapted from Parker, P.J. (1994). Protein kinase C: history and perspectives. In J.F.
Kuo (Ed.), Protein Kinase C, (p. 4). New York: Oxford University Press.
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ionophore A23 l 87.

For example, previous studies have shown that PMA acts

synergistically with A23187 to enhance the formation of LTs in human eosinophils
(Tamura, Agrawal, & Townley, 1988), human neutrophils (McColl, Hurst, &
Cleland, 1986; Liles, Meier, & Henderson, 1987; McIntyre, Reinhold, Prescott, &
Zimmerman, 1987) and murine macrophages (Humes, 1988; Tripp, Mahoney, &
Needleman, 1985). It has been envisaged that the simultaneous application of these
agonists may mimic the cellular events responsible for the release of free AA and/or
the activation of 5-LO as induced by physiologic stimuli (Liles et al., 1987). In fact,
there is evidence to suggest that the phosphorylation of specific target proteins by
PKC may intensify the A23 l 87-stimulated release of AA in several cell types
(Halenda, Zavoico, & Feinstein, 1985; Peters-Golden, McNish, Sporn, & Balazovich,
1991) as well as the biosynthetic activity of AA-selective phospholipase A2 (PLA2;
Lin, Lin, & Knopf, 1992; Lin, Wartmann, Lin, Knopf, Seth, & Davis, 1993).
In contrast, it has recently been demonstrated in human basophils that both
PMA and inhibitors of protein tyrosine kinase activity can effectively block the IL-3dependent formation of LTC4, indicating that while the IL-3 signaling pathways and
LTC4 production in these cells may depend on tyrosine phosphorylation, it does not
require the activation of PKC (Krieger, von Tschamer, & Dahinden, 1992).
Similarly, other laboratories have shown that co-stimulation with PMA specifically
attenuates LTC4 biosynthesis in differentiated human promyelocytic HL-60 cells
challenged with ionophore or with saturating concentrations of exogenous LTA4 (Ali,
Ford-Hutchinson, & Nicholson, 1994; Kargman, Ali, Vaillancourt, Evans, &
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Nicholson, 1994).
We designed the present study to evaluate the capacity of August (AUG) rat
mixed peritoneal leukocytes to generate LTC4 when challenged with different
concentrations of A23187 and to test the hypothesis that LTC4 biosynthesis in this
model is regulated via a serine/threonine-specific phosphorylation mechanism. The
AUG rat, which has a spontaneously high number of peritoneal eosinophils (Spry,
I 988) that can be harvested by a simple lavage procedure (Mackenzie, Jungery,
Taylor, & Ogilvie, 1981), is a potentially important animal model of eosinophilia that
has not been well characterized.

Parasite-independent, non-induced examples of

eosinophilia may prove particularly useful since both quantitative and qualitative
differences exist between different preparations of eosinophils depending on the
method of induction (Cook, Musgrove, & Ashworth, 1987).

MATERIALS AND METHODS
Animals
Eleven healthy adult male AUG rats (Harlan/Olac, UK) aged 27-35 wks were
used in this study.

Animals were housed at Western Michigan University

(Kalamazoo, MI) (68-72° C; 12 h-12 h light-dark cycles) in clear polycarbonate cages
and in accordance with the Institutional Animal Care and Use Committee (IACUC) at
this institution (Appendix A). Rodent chow #5001 (Purina Mills, St. Louis, MO) and
RO-purified water were provid.ed ad libitum.

Reagents
Except as noted below, all chemicals were purchased from Sigma Chemical
Co. (St. Louis, MO). MK-886 was a gift from Merck Frosst Canada (Montreal,
Canada). H-7 [ I-(5-isoquinolinesulfonyl)-2-methylpiperazine] was purchased from
Toronto Research Chemicals, Inc. (Ontario, Canada). Chelerythrine chloride and
genestein (4' ,5, 7-trihydroxyisoflavone) were from LC Laboratories (Woburn, MA).
The cytospin cell preparations were stained using Diff-Quik® Stain Sets from Baxter
Scientific Products (McGraw Park, IL). Stock solutions of agonists and inhibitors
were prepared in dimethyl sulfoxide (DMSO) (stock concentrations in mM: A23187,
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10; MK-886, 10; PMA, 8.1; chelerythrine chloride, 25; H-7, 5; genestein, 25) and
stored at -20 °C. When necessary, stocks were serially diluted immediately before
use with a NaHCO3 -free Hanks' Balanced Salt Solution (HBSS) containing 2.4 mM
+

+

+

Ca2 and 1.6 mM Mg2+. For Ca2 /Mg2 -free experiments, the A23 l 87 stock was
diluted with a Modified HBSS (without NaHCO3; CaC} i , or MgSO4). The final
concentration ofDMSO in the reaction mixture was never greater than 0.4 %. Huber,
Trautmann, Becker, Schenck, Peskar, & Schepp (1993) found that similar
concentrations of DMSO (0.37%) affected neither basal nor A23187-mediated LT
release in Wistar rat isolated gastric mucosa) cells.

Peritoneal Leukocyte Isolations
Rats were killed by carbon dioxide inhalation and a small ventral midline
incision was made exposing the peritoneal cavity. The resident peritoneal cells were
harvested by washing the cavity with 50 mL ofModified HBSS buffered with 20 mM
HEPES at pH 7.3. The lavage solution was aspirated by syringe and centrifuged at
200

x

g for 10 min at 4 ° C in a Beckman (Fullerton, CA) GS-6R refrigerated

centrifuge. The supernatant was discarded and the pelleted cells were resuspended in
5 mL Modified HBSS and kept on ice for subsequent experimental procedures.
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Cell Counts
An aliquot of the cell suspension was counted in a hemocytometer (American
Optical, Buffalo, NY), excluding red blood cells (RBC's) and cell fragments. The
cell density was adjusted to yield 3.0 x 106 cells/rnL with Modified HBSS.
Cytocentrifuge slide preparations were used to determine differential cell
counts in freshly isolated cell solutions. Briefly, IO µI of the cell suspension and 90
µI 0.1 M phosphate buffer were cytocentrifuged (in duplicate) at 600 rpm for 8 min
(Cytospin 3, Shandon Inc., Pittsburgh, PA). Air-dried slides were then fixed and
stained with a Diff-Quik® Stain Set and counted using a Nikon (Tokyo, Japan)
Microphot-FXA microscope.

Incubation Conditions
Counted cell suspensions from 2-3 animals were pooled for all experiments.
To elicit LTC4 biosynthesis, different concentrations of A23187 along with requisite
+

volumes of HBSS (final concentrations of 1.2 rnM Ca2+ and 0.8 mM Mg2 ) were
added to 0.5 rnL aliquots of the pooled cell suspension to equal a final volume of 1
rnL (1.5

x

+

+

106 cells). In Ca2 /Mg2 -free treatments, equal volumes of Modified HBSS

were substituted for the control HBSS.

The resulting reaction mixtures were

incubated for 10 min (37 ° C, with constant agitation). Some preparations were co
incubated with 0.5 µM A23 I 87 and 0.1 µM MK-886, a selective antagonist of LT
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synthesis (Gillard et al., 1989). In other experiments, cells were stimulated with 0.5
µM A23 l 87 in the presence of 50 nM PMA and/or each of the following protein
kinase inhibitors: (a) chelerythrine chloride (1.8 µM), a benzophenanthridine alkaloid
that is a putative highly specific PKC antagoinst (Herbert, Augereau, Gleye, and
Maffrand, 1990); (b) H-7 (6.0 µM), a nonspecific ·PKC inhibitor; or (c) genestein
(100 µM), an isoflavone compound that is a selective antagonist of tyrosine kinase
activity (Akiyama et al., I 987). The concentrations of the agonists and inhibitors
used have been previously shown by other investigators to be in the effective range
+

[Ca2 ionophore A23187 (Lindgren, Hammarstrom, & Goetz!, 1983); MK-886
(Rouzer, Ford-Hutchinson, Morton, Gillard, 1990); PMA and genestein (Ali, Ford
Hutchinson, & Nicholson, 1994); chelerythrine chloride (Herbert et al., 1990); and H7 (Kawamoto & Hidaka, 1984)]. All reactions were terminated by the addition of 3
mL ice-cold methanol and samples were subsequently stored at -70 ° C until
examination.

Assay of LTC4 Activity
The cell reaction mixtures were analyzed for LTC4 content by
acetylcholinesterase (AChE) enzyme immunoassay (EIA) (Cayman Chemical, Ann
Arbor, MI). All assay buffers and lyophilized reagents were reconstituted in ion
exchanged Millipore Milli-Q® purified water, 18 Mn. To prepare for analysis,
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samples were thawed and centrifuged at 1500 x g for 10 min at 4°C. The resulting
supematants were then evaporated to dryness in a heated (approximately 50 °C)
water bath under a stream of nitrogen. Dried samples were reconstituted in 1 mL of
assay buffer and stored overnight at 4°C. Each sample was assayed in duplicate.
Briefly, assay buffer, LTC4 standards, LTC4 AChE tracer, antisera, and the
reconstituted samples were aliquoted onto 96 well microtiter plates (pre-coated with
mouse monoclonal anti-rabbit lgG) according to the manufacturer's instructions. The
plates were covered with plastic film and incubated for 18 hr at room temperature.
To measure the bound AChE activity, 200 µl of enzyme substrate (Ellman's reagent)
was added to each well and the plates were developed in the dark on an orbital shaker
(Orbit Microprocessor Shaker Bath, Lab-Line Instruments, Melrose Park, IL).
Absorbance was read at 415 nm (Bio Rad Model 450 microplate reader, Richmond,
CA) when the readings of the maximum binding wells (maximum tracer-to-antiserum
binding in the absence of free LTC4 ) reached at least 0.3 absorbance units (AU.).
Results were calculated from a standard curve plot of% displacement of bound tracer
versus LTC4 concentration (pg/mL ).

Statistics
Standard curves were third or fourth-order regress10n curves (r2

�

0.95)

generated using Simga Plot® software (San Rafael, CA). All data are expressed as
mean± SEM. Homogeneity of variance was confirmed by Hartley's test and a two-
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tailed, unpaired Student's I-test or separate-variance t-test was used where
appropriate (Ott, 1988). A p value< 0.05 was considered significant.

RESULTS
Cell preparations used in all experiments contained a mixture of macrophages
(45 ± 1.0%), eosinophils (36 ± 0.8%), mast cells (11. ± 0.7%) and small lymphocytes
(8 ± 0.5%) (38.0± 2.0 x 106 total cells/harvest, mean± SEM; range, 29.5 x 106 -48.6
X

106 ).
Figure 3 shows the effect of various concentrations of calcium ionophore

A23 I 87 on the cellular generation of LTC4. Stimulation with 0.5 - 10.0 µM A23 l 87
for 10 min at 37 °C produced a dose-dependent release with a maximum (5.2 ± 0.3 ng
L TC4/106 cells) occurring at 5.0 µM. In some preliminary experiments, the smallest
detectable quantity of LTC4 was limited by the conditions under which the cell
+

+

supematants were assayed. For example, in the absence of both Ca2 and Mg2 the
stimulatory effects of A23 I 87 were completely abolished (Table 1), generating LTC4
levels that fell below the detection limit (all < approximately 0.03 ng/106 cells; n = 5)
when assayed at the same dilution as the control group (0.5 µM A23187). Similarly,
LT release was not observed in cells incubated in the absence of the ionophore
stimulus (n = 9; data not shown).
As an additional test of the integrity of the LT biosynthetic pathway, we
assessed the affects of MK-886, a potent FLAP antagonist (Rouzer, Ford-Hutchinson,
Morton, & Gillard, 1990; Gillard et al., 1989), on the cellular generation of LTC4. At
17
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Figure 3. Calcium Ionphore A23 l 87 Stimulates LTC4 Synthesis in a DoseDependent Manner.
Aliquots (1.5 x 106 cells) of AUG rat mixed peritoneal leukocytes in HEPES
+
+
buffered HBSS (containing 1.2 mM Ca 2 and 0.8 mM Mg2 , pH 7.3) were incubated
with 0.5 - 10.0 µM A23187 in DMSO (maximum vechicle concentrations 0.4 %)
for 10 min at 37 °C. Reactions were terminated by the addition of methanol, and the
levels of LTC4 determined by EIA (Cayman Chemical, Ann Arbor, MI). Data are
expressed as the mean of 4 - 14 duplicate experiments and are shown ± SEM.
*Significantly different from 0.5 µM A23187 treatment (p < 0.05).
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0.1 µM, this agent significantly inhibited 0.5 µM A23187-stimulated LT synthesis by
approximately 92 % (p < 0.05; n = 6) (Table 1).
Next, we investigated the possible regulatory role of PKC in the A23 I 87stimulated synthesis of LTC4 by co-incubating some isolates with 50 nM PMA, a
diterpene phorbol ester capable of directly activating PKC in vitro (Castagna et al.,
1982). As evidenced in Figure 4 (column 1 vs. column 2), PMA significantly
inhibited LTC4 release in response to 0.5 µM A23187 by approximately 66% (p <
0.05; n = 7).
To confirm that activation of PKC was indeed responsible for the observed
down-regulation ofLTC4 release in PMA-treated cells, we employed two functionally
distinct inhibitors of PKC activity (Herbert et al., 1990; Hidaka, Inagaki, Kawamoto,
& Sasaki, 1984). However, neither chelerythrine chloride (1.8 µM) nor H-7 (6.0
µM; n = 4 for both groups) were able to abrogate the effects ofPMA at the
Table 1
+

+

Ca2 , Mg2 and 5-Lipoxygenase Activating Protein (FLAP) Activity Are Essential for
Ca2+ Ionophore A23187-Stimulated LTC4 Synthesis
Treatment
0.5 µM A23187
0.5 µM A23187
0.5 µM A23187 + 0.1 µM MK-886

1.2 mM Ca2
+

+

+

0.8mM Mg2
+

+

+

6
a
pg LTCJ l 0 Cells

577.3 ± 60.9 (14)
ND (5)b
46.3 ± 3.0 (6)*

Results expressed as mean ± SEM with the number ofduplicate experiments given
in parentheses.
b ND = Not detectable when assayed at the same dilution as the control group.
* Significantly different from control (p < 0.05).
a

20

800

600
.....I
()

400
()
.....I

200

0
<{

+
w

z

_J

0
a::

I-

z

0

::!!:

a..

er
I
I-

>-

a::

w
_J
w

w

z

erI
�

a::

w
_J
w
I

<{

<{
:!;

a..

+

±

I'-

(.)

::E
a..

±

I'-

z

wI-

w
z
w
Cl)

z

wI-

w
z
w
Cl)

C)

C)

PKC

[;]

Figure 4. LTC4 Biosynthesis is Attenuated by PKC Activation and PTK Inhibition in
A23187-Challenged AUG Rat Mixed Peritoneal Leukocytes.
Aliquots (1.5 x 106 cells) of AUG rat mixed peritoneal leukocytes in HEPES buffered
+
+
HBSS (containing 1.2 mM Ca2 and 0.8 mM Mg2 , pH 7.3) were incubated with 0.5
µM A23187 in DMSO (maximum vechicle concentrations 0.4 %) in the presence of
the indicated agent(s) (PMA, column 2; chelerythrine chloride + PMA, column 3;
chelrythrine chloride, column 4; H-7 + PMA, column 5; H-7, column 6; genestein +
PMA, column 7; genestein, column 8) for 10 min at 37 °C. Reactions were terminated
by the addition of methanol, and the levels of LTC4 determined by EIA (Cayman
Chemical, Ann Arbor, MI). Data are expressed as mean ± SEM of 4 - 14 duplicate
experiments (see text). *Significantly different from control group (p < 0.05).
**Significantly different from control group and significantly different from same
inhibitor in the presence of PMA (p < 0.05). ***Significantly different from PMA
treatment group (p < 0.05).
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concentrations tested (columns 3 and 5 vs. column 2); in fact, chelerythrine further
inhibited LT synthesis by another 24% (p < 0.05; H-7 plus PMA vs. A23187 plus
PMA not significant, p > 0.05). Consequently, we next tested the independent ability
of each inhibitor to modulate LT production in the absence of PMA. As shown in
Figure 4 ( columns 4 and 6 vs. column I), both agents significantly down-regulated
the synthesis ofLTC4 when compared to cells treated with ionophore alone (p < 0.05,
n = 4 for both groups). Interestingly, the inhibitory response to chelerythrine did not

differ appreciably between A23 l 87 or A23 l 87 plus PMA treatments (columns 3 and
4; p > 0.05), suggesting that chelerythrine may be operating in a fashion that is
independent of PKC activation.

On the other hand, the response to H-7 was

significantly more pronounced in the absence of PMA (column 6 vs. column 5; p <
0.05). Although the reasons for this discrepancy remain unclear, the problems
involved with the specificity of H-7 for PKC have been considered previously
(Garland et al., 1987).
Gilmore & Martin (1983) demonstrated that PMA can effect tyrosine-specific
as well as serine/threonine-specific phosphorylation events, suggesting that PMA may
interact with PTK as well as PKC. To study this possibility, we measured the level of
LTC4 production in A23187- and A23187 plus PMA-challenged cells treated with
100 µM genestein, a selective inhibitor of PTK activity (Akiyama et al., 1987). As
shown in Figure 4 (column 7 vs. column 2), PTK inhibition did not prevent the
antagonism of PMA on LTC4 synthesis, but rather enhanced this effect by another.
31 % (p < 0.05, n = 5). Since genestein also inhibited mediator formation in cells

challenged with 0.5 µM ionophore alone (p < 0.05, n = 3; column 8 vs. column I), we
suggest that LTC4 biosynthesis in these cells may be regulated via serine/threonine
and tyrosine-specific phosphorylation mechanisms in an antagonistic fashion; a
phenomenon previously demonstrated, following IL-3 preincubation, in C5a
stimulated human basophils (Krieger et al., 1992).
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DISCUSSION
Eosinophils may play an important role in such diverse pathologies as
bronchial asthma (Butterfield & Leiferman, 1993; Kay, 1991) and helminth parasitic
infestations (Butterworth & Thorne, 1993).

Thus, a clear understanding of the

processes involved in activation and secretion by these cells is of obvious value.
However, the study of eosinophil function has been difficult, due to the inherent
problems involved in isolating homogeneous populations of viable cells, particularly
since the method used in recruitment may have a marked effect on their responses in
vitro (Cook et al., 1987). Recent work in our laboratory (see also Orcutt, 1994) has

utilized the syngeneic AUG rat strain, which has a high spontaneous number of
peritoneal eosinophils (Spry, 1988), to provide a consistent and reliable source of
these cells.
As part of a larger cooperative effort to understand the biology of the
peritoneal cell population in this animal, the present in vitro study demonstrates the
calcium/magnesium ion and dose-dependent stimulation of LTC4 biosynthesis by the
calcium ionophore A23187, and further, the inhibition of this response by MK-886
(Gillard et al., 1989), a specific antagonist of FLAP activity (Rouzer, Ford
Hutchinson, Morton, & Gillard, 1990). Because MK-886 reportedly binds FLAP at a
site corresponding to its putative AA binding domain (reviewed in Ford-Hutchinson,
1994 ), thereby preventing the efficient transfer of AA to 5-LO (Ford-Hutchinson,
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1994; Miller et al., 1990), the findings presented here thus suggest that the incipient
complex cellular events leading to the de novo fonnation of LTC4 are intact in
isolated AUG rat mixed peritoneal cells.
Control of LT biosynthesis lies, at least in part, with the remarkably cell
specific expression of the tenninal enzymes. Depending on cell phenotype and the
species or tissue source, leukocytes preferentially express either LTAi hydrolase or
LTC4 synthase and thus are capable of synthesizing their respective products with
singular specificity. For example, human alveolar macrophages (AMs) are capable of
secreting only LTB4 (Martin, Altman, Albert, & Henderson, 1984; Fels, Pawlowski,
Cramer, King, Cohn, & Scott, 1984), while both murine and rat AMs are able to
conjugate LTAi to LTC4 (Rouzer et al., 1982; Rankin et al., 1984). Although we did
not directly identify the cellular source of LTC4 production in our model, peritoneal
macrophages (Wenzel, Trudeau, Riches, Westcott, & Henson, 1993), eosinophils
(reviewed in Gleich et al., 1992), and some populations of mast cells (reviewed in
Raible & Lichtenstein, 1988) have all been implicated as important sources of this
lipid mediator in other systems. Moreover, in the tissue reactions associated with
several inflammatory disease processes, such bronchial athsma, it is unlikely that any
one cell phenotype or secreted mediator is responsible for all of the clinical
manifestations accompanying pathogenesis (Kay, 1991).

Nevertheless, current

investigations in our laboratory are quantifying peritoneal leukocyte LTC4 release in
AUG rats infected with the nematode Nippostrongylus brasiliensis (R. Eversole,
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unpublished data), a technique previously shown to stimulate blood eosinophilia and
basophilia in this animal (Ogilvie, Hesketh, & Rose, 1978; Ogilvie, Askenase, &
Rose, 1980).

Along with novel cell separation or depletion tools, such as

Dynabeads® M-450 CD14 (DYNAL, Inc., Lake Success, NY) or discontinuous
metrizamide gradient centrifugation (Mackenzie · et al., 1981) for suspended
macrophages and eosinophils respectively, these studies should allow us to determine
the relative contributions made by specific cell types to the total eicosanoid
production in both infected and uninfected states.
In view of the broad spectrum of agonists that can trigger the breakdown of
inositol phospholipids (reviewed in Meldrum, Parker, & Carozzi, 1991), it is not
surprising that PKC has been implicated in a multitude of short-term and long-term
cellular responses.

For example, previous studies have shown that PMA and

suboptimal or threshold concentrations of A23187 synergistically potentiate the
synthesis of LTC4 in human eosinophils (Tamura et al., 1988) and murine
macrophages (Humes, 1988; Tripp et al., 1985). However, consistent with recent
findings in human basophils (Krieger et al., 1992), human platelets (Edinius et al.,
1995), and differentiated substrains of the human promyelocytic HL-60 cell line (Ali
et al., 1994; Kargman et al., 1994), our data suggest that PMA-mediated activation of
PKC negatively regulates cysteinyl LT biosynthesis in AUG rat mixed peritoneal
leukocytes. Since it can also be demonstrated in other non-immunologic cell types
that activation of PKC does not effectively modulate LTC4 release in response to
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A23187 (Huber et al., 1993), it thus appears likely that the regulation of this
biosynthetic pathway may differ substantially across species, compartments or cell
phenotypes.

This is almost certainly the case in the cell-cell cooperation (i.e.,

transcellular biosynthesis) where LTAi is transferred from donor neutrophils to 5-LO
deficient acceptor cells, such as platelets (Maclouf & Murphy, 1988), endothelial
cells (Feinmark & Cannon, 1986), and vascular smooth muscle cells (Feinmark &
Cannon 1987; Feinmark, 1988), and is subsequently conjugated with GSH via LTC4
synthase.
On the other hand, this interpretation does not fully explain the observations
of other PMA-mediated effects, such as the potentiation of A23187-stimulated AA
release (Halenda et al., 1985; Peters-Golden et al., 1991), the activation of AA
selective PLA2 (Lin, et al., 1992; 1993), or the stimulation of prostanoid formation
via the transcriptional activation of the cyclooxygenase-2 gene (Gilbert &
Herschman, 1993; Kujubu, Fletcher, Varnum, Lim, & Herschman, 1991). In fact,
PKC is known to stimulate or enhance prostanoid biosynthesis in several cell types
(Ali et al., 1994; Humes et al., 1982; Ota et al., 1993; Peters-Golden, Coburn, &
Chauncey, 1992; Simonson, Wolfe, Konieczkowski, Sedor, & Dunn, 1991; Thore,
Nam, & Busija, 1994; Yokota, 1991). One plausible interpretation of these findings
is the mechanism proposed by Ali et al. (1994; 1995) whereby the phosphorylation of
LTC4 synthase, or a putative modulator of its activity, non-competitively inhibits
LTC4 biosynthesis, and the profile of eicosanoid mediators shifts from cysteinyl LTs

towards the cyclooxygenase products of AA metabolism. The rapid accumulation of
pharmacologically inactive LTAi would not necessarily be reflected in higher levels
of LTB4 production, since LTAi hydrolase is saturated at 40 µM LTA4 ( Ali et al.,
1994).

If true, this hypothesis suggests a novel negative feedback mechanism

whereby potent mediators such as L TD4 can both ·attenuate their own production
through binding receptors that trigger the activation of phosphatidylinositol-specific
phospholipase C (Ptdins-PLC; Crooke, Mong, Sarau, Winkler, & Vegesna, 1988)
(refer to Figure 2) and concomitantly stimulate the synthesis of other mediators (i.e.,
prostaglandins) some of which may counteract their physiological actions in tissues
(Ali et al., 1994).
In the present study, we were unable to prevent the effects of PMA by the
application of two structurally distinct PKC antagonists, chelerythrine chloride (IC50
= 0.7 µM) (Herbert et al., 1990) and the isoquinolinesulfonamide H-7 (Ki for PKC =
6.0 µM) (Hidaka, Inagaki, Kawamoto, & Sasaki, 1984).

Given that the PMA

mediated activation of PKC is both widely accepted and well documented at the
concentrations used in our experiments, we suggest that these data indicate probable
non-specific or toxic drug effects relating to the inhibitors themselves, rather than any
PKC-independent effects of the phorbol ester. This interpretation is facilitated by the
facts that (a) both chelerythrine chloride and H-7 were potent inhibitors of LTC4
biosynthesis in their own right and, in the case of H-7, these effects may actually be
partially averted by PMA or PMA-induced PKC activation; (b) both agents were only
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tested during short-term incubations at a single dose, raising the possibly that the
drugs may, in fact, be sufficiently effective against PKC at alternate concentrations
and/or longer exposure periods; (c) H-7 inhibits PKC by competing with ATP for the
catalytic site (Hidaka et al., 1984) and hence is non-specific, since most protein
kinases, as well as several enzymes, utilize ATP as a substrate (Mahoney & Huang,
1994; see also Garland et al., 1987); (d) the chelerythrine-induced antagonism of LT
synthesis described here was not significantly different in either the presence or
absence of phorbol ester, suggesting that the inhibitory effects of the compound are
independent of, or superlative to those mitigated by PMA; and finally, (e) at least one
other whole-cell mediator release study (von Stebut, Amon, Herbert, & Wolff, 1994),
encountered conflicting results between chelerythrine and other specific PKC
inhibitors, suggesting that chelerythrine may be less selective for PKC. Thus, a
conservative interpretation of the data presented here would be that chelerythrine
chloride and H-7 may have potent effects either wholly or partially unrelated to the
inhibition PKC activity. In view of the scope of our objectives, however, any putative
non-specific properties relating to these compounds remain unclear.
Recently, a number of investigators have shown a PTK inhibitor-dependent
attenuation of LT biosynthesis (Atluru, Jackson, & Atluru, 1991; Krieger et al., 1992;
Atluru & Gudapaty, 1993; Hagman, 1994), suggesting that tyrosine phosphorylation
may play a role in the short-term responses associated with the formation of these
lipid mediators. Consistent with the recent demonstration of antagonism between
serine/threonine and tyrosine-specific phosphorylation mechanism in the IL-3-
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dependent formation of LTC4 by human basophils (Krieger et al., 1992), our study
shows that A23187-stimulated LTC4 synthesis in AUG rat peritoneal leukocytes can
be blocked by the application of a selective PTK antagonist. Simultaneous treatment
with both genestein and PMA also significantly enhances the inhibitory properties of
either agent alone, suggesting that the effects of PKC ·activation and PIK-antagonism
may be additive. However, these data need to be interpreted with caution, since non
specific drug effects cannot be entirely ruled out, especially as genestein, like H-7, is
a competitive inhibitor with respect to ATP (Akiyama et al., 1987). Moreover, two
recent studies have shown several unrelated antagonists of PTK activity to be
ineffective in down-regulating cysteinyl LT biosynthesis in other cell types (Ali et al.,
1994; Kargman et al., 1994).

Nevertheless, genestein only weakly inhibits the

activity of serine/threonine specific kinases in vivo (Akiyama et al., 1987; Akiyama
and Ogawara, 1991) indicating that non-specific activation of PKC is probably very
unlikely.

Further studies with mechanistically dissimilar PTK antagonists (see

review, Levitzki & Gazit, 1995) are needed to interpret the role of tyrosine
phosphorylation in the synthesis of this bioactive lipid mediator. Inasmuch as the
pharmacological activities of the L Ts suggest a role in the pathophysiology of
immediate hypersensitivity diseases (Lam & Austen, 1992), these findings could
ultimately provide a useful basis for drug development targeted at lessening the
severity of tissue reactions associated with inflammation.
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